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The NLRP3 inflammasome is activated by a variety of external 
or host-derived stimuli and its activation initiates an in-
flammatory response through caspase-1 activation, resulting in 
inflammatory cytokine IL-1 maturation and secretion. The 
NLRP3 inflammasome activation is a kind of innate immune 
response, most likely mediated by myeloid cells acting as a 
host defense mechanism. However, if this activation is not 
properly regulated, excessive inflammation induced by over-
activated NLRP3 inflammasome can be detrimental to the 
host, causing tissue damage and organ dysfunction, eventually 
causing several diseases. Previous studies have suggested that 
mitochondrial damage may be a cause of NLRP3 inflammasome 
activation and autophagy, which is a conserved self-degradation 
process that negatively regulates NLRP3 inflammasome acti-
vation. Recently, mitochondria-selective autophagy, termed 
mitophagy, has emerged as a central player for maintaining 
mitochondrial homeostasis through the elimination of damaged 
mitochondria, leading to the prevention of hyperinflammation 
triggered by NLRP3 inflammasome activation. In this review, 
we will first focus on the molecular mechanisms of NLRP3 
inflammasome activation and NLRP3 inflammasome-related 
diseases. We will then discuss autophagy, especially mitophagy, 
as a negative regulator of NLPP3 inflammasome activation by 
examining recent advances in research. [BMB Reports 2016; 
49(10): 529-535]
INTRODUCTION
The immune system is a host protection mechanism against 
invading pathogens, such as viruses and bacteria. Macrophages, 
the front line defenders who recognize invading pathogens, 
not only kill pathogens by phagocytosis, but also initiate 
inflammation producing inflammatory cytokines upon 
infections. The maturation and secretion of IL-1, one of the 
strongest pro-inflammatory cytokines, is enhanced by the 
inflammasome in macrophages, leading to inflammation and 
cell death (1, 2). 
Inflammasomes are molecular platforms that trigger activation 
of caspase-1, leading to pro-inflammatory cytokine maturation. 
One of the best characterized inflammasome is the NLRP3 
inflammasome. Even though NLRP3 inflammasome activation 
is important for protecting cells from pathogenic microbes, 
excessive NLRP3 inflammasome may cause hyperinflammation 
resulting in tissue damage and organ failure. NLRP3 in-
flammasome is also activated by danger signals released from 
stressed cells and dysregulation of NLRP3 inflammasome 
activation causes many diseases, such as neurodegenerative 
diseases, metabolic diseases and sepsis. Therefore, mechanisms 
to control NLRP3 inflammasome activation are necessary for 
health. 
Upon bacterial infection, innate immune cells, such as 
macrophages and neutrophils, take up bacteria and generate 
reactive oxygen species (ROS) (3-5). The 2 main sources of 
ROS are NADPH oxidase-mediated ROS and mitochondria- 
derived ROS in innate immune cells (6-8). Some studies have 
proposed that mitochondrial dysfunction is closely associated 
with NLRP3 inflammasome activation. Infection causes 
mitochondrial damage through an unknown mechanism and 
the damaged mitochondria release mitochondrial DNA 
(mtDNA) and mitochondrial reactive ROS (mtROS) and are 
thought to work as danger signals (9, 10). Cells have a 
regulatory mechanism, ‘mitophagy’, a mitochondria-selective 
autophagic process to eliminate damaged or unwanted 
mitochondria, to maintain mitochondrial homeostasis against 
stress. This review will discuss how the balance between 
pro-inflammatory response and anti-inflammatory response is 
maintained in cells focusing on NLRP3 inflammasome 
activation and mitophagy. 
THE INFLAMMASOME
Inflammation is one of the first innate immune responses to 
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combat foreign organisms entering the body that are able to 
cause disease (11). Most foreign organisms express various 
pathogen-associated molecular patterns (PAMPs) in their cell 
wall or on their cell surface (12). Therefore, it is possible that a 
host can distinguish between self and non-self by recognizing 
PAMPs. Moreover, under stressed conditions, cells release 
danger signals called danger-associated molecular patterns 
(DAMPs) to notify their urgent situation to the immune system. 
PAMPs and DAMPs are recognized by innate immune 
receptors pattern-recognition receptors (PRRs), such as Toll-like 
receptors (TLRs) and nucleotide-binding and oligomerization 
domain (NOD)-like receptors (NLRs) (13). Activation of PRRs 
lead to Nf-B activation and inflammatory cytokine production. 
Many studies have shown that the inflammasome is a key 
regulator of inflammation (1, 14-17). Most inflammasomes 
contain NLR proteins and the NLR family can be classified into 
3 subtypes based on their domain structures: the NODs 
(NOD1-5 and CIITA), the NLRPs (NLRP1-14) and the IPAF 
(IPAF also known as NLRC4, and NAIP) subtypes (18). The 
NLR family commonly contains a central nucleotide-binding 
and oligomerization (NACHT) domain. Most NLRs also 
contain C-terminal leucine-rich repeats (LRRs) and N-terminal 
caspase recruitment domains (CARD) or pyrin domains (PYD). 
NACHT plays an essential role in the activation and formation 
of signaling complexes and LRR mediates ligand sensing, 
while CARD and PYD function in homotypic protein-protein 
interactions for downstream events (18, 19). A non-NLR in-
flammasome member, absent in melanoma-2 (AIM2), was later 
identified that can form an inflammasome composed of AIM2, 
ASC and caspase-1. The function and mechanism of many 
NLR family members remain poorly understood, but some are 
well-characterized. For example, NOD1 and NOD2 are 
receptors for bacterial peptidoglycan fragments. NOD1 and 
NOD2 recognize D-glutamyl-meso-diaminopimelic acid (DAP) 
and muramyl dipeptide (MDP), respectively. Upon sensing 
their ligand, NOD1 and NOD2 oligomerize and recruit RIP2 
via CARD-CARD interactions, triggering an inflammatory 
response (20, 21). CIITA uniquely acts as a transcription factor 
playing a key role in the regulation of class II MHC genes (22). 
The IPAF inflammasome is activated in response to gram- 
negative bacteria containing type III or IV secretion systems, 
such as Psudomonas aeruginosa, Salmonella typhimurium and 
Shigella flexneri (23-25). The AIM2 inflammasome is activated 
by sensing cytosolic double-stranded DNA (dsDNA) through 
the HIN-200 domain of AIM2 (26, 27). As is demonstrated 
herein, each inflammasome is activated by different stimuli, 
but more studies concerning other NLR family members are 
required. In this review, the NLRP3 inflammasome, which is 
the most characterized of the inflammasome members, will be 
discussed in detail. 
NLRP3 INFLAMMASOME
The NLRP3 inflammasome is activated in response to abundant 
stimuli and 2 distinct steps are required for this activation. 
First, Nuclear factor-B (NF-B) activation by TLR ligands 
increases NLRP3 and pro-1L-1; this step is called ‘priming’. 
Second, activating stimuli derived from microbes or the host 
induce the assembly of NLRP3 inflammasome components 
(17). The NLRP3 inflammasome is composed of NLRP3, 
apoptosis-associated speck-like protein containing a CARD 
(ASC) and pro-caspase-1. ASC is an inflammasome adaptor 
containing N-terminal PYD and C-terminal CARD. NLRP3 
inflammasome is assembled by the following steps: PYD of 
NLRP3 is oligomerized with ASC through PYD-PYD interactions. 
Subsequently, pro-caspase-1 is recruited and interacts with 
ASC through CARD-CARD interactions (28). After the formation 
of the NLRP3 inflammasome, pro-caspase-1 is autocleaved to 
active caspase-1 and the active caspase-1 matures cytokines, 
such as IL-1, to their bioactive and secreted forms (17). 
Currently, various sterile DAMP signals and pathogens, 
including mitochondrial ROS, mitochondrial DNA, potassium 
efflux, MDP, monosodium urate (MSU), cholesterol crystals, 
cathepsins, influenza virus, Salmonella typhimurium, Myco-
bacterium tuberculosis and others, are known to activate the 
NLRP3 inflammasome (29). Compared to NLRP3 inflammasome 
activators, negative regulators of the NLRP3 inflammasome are 
relatively less known. Recent studies suggest that nitric oxide 
(NO), Ca2＋ and cyclic AMP negatively regulate the NLRP3 
inflammasome but the detailed mechanisms are unclear (30, 
31). If the upregulated NLRP3 inflammasome activation is not 
downregulated, inflammation will be persistently induced by 
NLRP3 inflammasome and contribute to a diverse array of 
diseases.
NLRP3 INFLAMMASOME IN DISEASE; 
NEURODEGENERATIVE DISEASE
Dysregulation of NLRP3 inflammasome activation is observed 
in neurodegenerative disease. Alzheimer’s disease (AD), a 
representative neurodegenerative disease, is characterized by 
amyloid- plaque accumulation. Halle et al., using in vitro and 
in vivo mouse models, identified that amyloid- causes 
lysosomal damage releasing cathepsin B and the cathepsin B 
activated NLRP3 inflammasome (32). In addition to the mouse 
study, recently performed human studies showed that 
increased active caspase-1 expression is observed in the brains 
of AD patients (33). It has been reported that not only AD but 
also Parkinson’s disease (PD) are associated with the NLRP3 
inflammasome. Accumulation of Lewy bodies (LB) formed by 
-synuclein (Syn) aggregation is a main pathogenesis of PD. 
A recent study revealed that Syn induces synthesis of 
pro-IL-1 by an interaction with TLR2 and activates NLRP3 
inflammasome resulting in caspase-1 activation and IL-1 
maturation in human primary monocytes (34). In contrast, it is 
reported that mitochondrial dysfunction may lead to neuro-
degenerative disease (35). These studies indicate that both the 
NLRP3 inflammasome and mitochondrial dysfunction are 
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involved in neurodegenerative disease though more studies 
are required to clarify the relationship among NLRP3 
inflammasome, mitochondria and neurodegenerative diseases. 
NLRP3 INFLAMMASOME IN DISEASE; METABOLIC 
DISORDER
It has been known that a High fat diet (HFD) can induce Type 
2 diabetes (T2D) and obesity and chronic inflammation is 
thought to contribute to T2D and obesity (36). As such, there 
is a possibility that the NLRP3 inflammasome, which can lead 
to chronic inflammation, is related to these metabolic diseases. 
Recently Lee et al. observed the activated NLRP3 inflamma-
some in T2D patients and found that mitochondrial ROS is 
involved in this phenomenon (37). Other groups showed that 
saturated fatty acid-induced inflammation causes mitochondrial 
impairment in adipocytes, while saturated fatty acids can 
upregulate NLRP3 inflammasome activation (38, 39). Also, a 
higher level of NLRP3 inflammasome components were 
detected in obese patients, and active caspase-1 were 
increased with obesity development in adipose tissues (40). 
Interestingly, caspase-1 deficient mice gained less weight and 
they had less adipose tissue formation in the HFD-induced 
obesity mouse model (41). These data strongly suggest that the 
NLRP3 inflammasome and mitochondrial dysfunction are 
closely linked to metabolic disorders. 
NLRP3 INFLAMMASOME IN DISEASE NLRP3; SEPSIS
Sepsis is a life-threatening systemic inflammatory condition 
caused by a host immune response to microbial infection. 
Normally, increased inflammatory response to infection should 
be resolved in a timely manner, but when it gets out of 
control, exaggerated activation of the inflammasome produces 
excessive inflammatory cytokines leading to sepsis. A few 
studies provided evidence that mitochondrial dysfunction is 
associated with sepsis. Damaged mitochondria of the cells 
treated with NLRP3 inflammasome activators release danger 
signals, such as mtROS and mtDNA, and these signals can 
activate the NLRP3 inflammasome (9, 10). Supporting these, 
increased mtDNA and inflammatory cytokines were detected 
in septic plasma samples (42). This evidence shows that both 
the NLRP3 inflammasome and mitochondria contribute to 
sepsis. 
MITOCHONDRIA AND NLRP3 INFLAMMASOME
Mitochondria are double membrane organelles that play 
pivotal roles in cells, including energy production and 
regulation of cell death. In addition, recent studies have 
revealed that mitochondria are also involved in the innate 
immune response (43, 44). Mitochondria are the main sites of 
reactive oxygen species (ROS) production. Mitochondrial ROS 
are not just byproducts of aerobic respiration, but also 
participate in signaling pathways. However, overproduced 
ROS can cause cell damage and contribute to pathologies. 
Some studies have shown that ATP and monosodium urate 
(MSU) crystals increase ROS production and these activate the 
inflammasome (45, 46). Silica and asbestos also increase ROS 
production and activate the NLRP3 inflammasome (47). In 
another study, increased mtROS by the inhibition of mitochon-
drial complex I or complex III, triggered NLRP3 inflammasome 
activation, indicating mtROS can be a main cause of NLRP3 
inflammasome activation (48, 49). mtDNA also activates 
NLRP3 inflammasome. Under normal conditions, mtDNA is 
located in mitochondria; however, when mitochondria are 
damaged, mtDNA is released into the cytoplasm. Shimada et 
al. found that oxidized mtDNA released from damaged 
mitochondria directly induced the NLRP3 inflammasome (10). 
Mitochondrial outer membrane proteins are also thought to 
activate the NLRP3 inflammasome. Mitofusins, mitochondrial 
outer membrane proteins that are required for mitochondrial 
fusion, activate the NLRP3 inflammasome in influenza and 
encephalomyocarditis virus (EMCV) infection, while another 
mitochondrial outer membrane protein MAVS recruits NLRP3 
to mitochondria and activates inflammasome activation in 
response to ATP, nigericin and poly I:C (50). All of these data 
indicate that mitochondria play a crucial role in NLRP3 
inflammasome activation. 
AUTOPHAGY AND NLRP3 INFLAMMASOME
As described above, there is a lot of evidence to suggest that 
damaged mitochondria contribute to disease, including NLRP3 
inflammasome-related diseases. Therefore, the importance of 
mitophagy, which is a process to remove damaged mitochon-
dria, can be considered as a key process to regulate NLRP3 
inflammasome activation. Despite the importance of mitophagy, 
it has mostly only been studied in mitochondria-related gene 
overexpressed mammalian cell lines in recent years. To 
investigate its mechanism and function accurately, more in 
vitro and in vivo studies are required. Knowledge of 
macroautophagy (hereafter autophagy) is a prerequisite to 
understanding mitophagy. Autophagy is a self-degradation 
process to recycle cellular components under stressed 
conditions, such as lack of nutrients. Autophagy has been 
regarded as a nonselective process in the past; however, 
accumulating evidence shows that it can be selective to 
remove specific proteins and damaged organelles, such as 
mitochondria under certain conditions (51-53). Autophagy 
consists of 4 sequential steps: initiation of autophagosome 
formation, elongation and closure of autophagic membrane, 
fusion between autophagosome and lysome, and degradation. 
In many cellular cases, autophagic induction is regulated by 
the mammalian target of rapamycin (mTOR) and the 
AMP-activated protein kinase (AMPK). mTOR inactivates 
unc-51-like kinase 1/2 (ULK1/2) by phosphorylation under 
basal conditions, but mTOR is inhibited under stress 
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Fig. 1. Mitophagy downregulates aberrant NLRP3 inflammasome 
activation. NLRP3 inflammasome stimuli activates NF-B producing
NLRP3 and pro-IL-1. Mitochondria are damaged by NLRP3 in-
flammasome stimuli and release NLRP3 inflammasome activating 
signals, such as mtDNA and mtROS, triggering an inflammatory 
response. Mitophagy downregulates NLRP3 inflammasome activation
by eliminating damaged mitochondria, blocking NLRP3 inflam-
masome activating signals.
conditions, allowing ULK1/2 to be modified to their active 
forms by AMPK phosphorylation initiating autophagy. Next, 
VPS34 lipid kinase complex and phosphatidylinositol 
3-phosphate (PI3P) are recruited to complete autophagosome 
formation. In the step of elongation and closure of the 
autophagic membrane, the ubiquitin-like proteins, ATG12 and 
ATG5, are conjugated and then the conjugated forms an 
E3-like ligase complex with ATG16L1. After that, ATG8 (LC3 
and GABARAP subfamilies) is conjugated to the lipid 
phosphatidylethanolamine by the ATG16L1 ligase complex 
and in the case of LC3, LC3-I form changes to LC3-II form, 
which is often used as an autophagosome marker (44, 54). 
VPS34–Beclin 1 complex containing ultraviolet radiation 
resistance associated gene protein (UVRAG) is involved in the 
step of fusion between the autophagosome and lysosome. 
Once the autophagosome and lysosome are fused to the 
autolysosome, the cargo in the autolysosome is degraded 
through lysosomal hydrolase activity (55). When there are 
certain proteins or organelles to be eliminated, they are 
ubiquitinated by E3 ubiquitin ligases and the ubiquitin chains 
serve as ‘eat-me’ signals. Then, adaptor proteins, such as p62 
and NBR1, which contain a ubiquitin-associated UBA domain 
and LC3-interacting region (LIR), capture the ubiquitinated 
cargos and recruit LC3-II to proceed to selective autophagy 
(54). Accumulating evidence has shown that autophagy is 
involved in the innate immune response and NLRP3 inflam-
masome activation. Inhibition of autophagy by 3MA, which is 
a PI3K inhibitor increased mtROS production resulting in 
NLRP3-dependent IL-1 secretion in the absence of inflam-
masome stimuli (56, 57). Similarly, treatment of 3MA blocking 
autophagosome formation in Mycobacterium tuberculosis- 
infected cells led to increased IL-1 secretion (58). Consistent 
with these data, bone marrow-derived macrophages from LC3 
knockout mice and Beclin 1 knockout mice had more 
damaged mitochondria producing mtROS, and had more 
caspase-1 activation leading to increased IL-1 secretion upon 
NLRP3 inflammasome activation (9). Also, Atg16L1 deficient 
mice were more susceptible to dextran sulfate sodium-induced 
colitis as a result of enhanced inflammasome activation (58). 
These data show that autophagy negatively regulates in-
flammasome activation. Moreover, as damaged mitochondria 
are detected at higher levels under autophagy inhibition (9, 
56, 57), it is plausible to assume that the elimination of 
damaged mitochondria by autophagy is important to prevent 
excessive NLRP3 inflammasome activation. 
MITOPHAGY AND NLRP3 INFLAMMASOME
As mentioned above, mitochondrial damage causes NLRP3 
inflammasome, and mitophagy can remove damaged mito-
chondria selectively (Fig. 1). Since mitochondria are evolved 
from ancient bacteria, a comparison of differences between 
mitophagy and intracellular bacteria-selective autophagy referred 
as to xenophagy can provide valuable information to better 
understand mitophagy. Distinguishing between self and 
non-self is achieved by different ‘eat-me’ signals and cargo 
receptors (52, 59). To date, at least 4 cargo receptors have 
been studied in detail: NDP52, p62, NBR1 and Optineurin 
(59). Invading bacteria can damage their host vacuoles in 
which the bacteria replicate exposing glycans from the host 
vacuoles, and the glycans are recognized by a danger receptor, 
Galectin-8. Galectin-8 functions as an ‘eat-me’ signal and 
interacts with NDP52 inducing xenophagy by recruiting LC3 
attached to phagophores (60). NDP52 can also directly bind to 
ubiquitinated bacteria and recruit the autophagic machinery. 
Similarly, p62, NBR1 and Optineurin serves to connect 
ubiquitinated bacteria with LC3, facilitating autophagy. How 
the engulfed bacteria are ubiquitinated is still largely unknown 
but LRSAM1 has been identified as an E3 ubiquitin ligase that 
ubiquitinates Salmonella typhimurium recruiting cargo 
receptors (61). Another E3 ubiquitin ligase, PARKIN, has also 
been reported to be involved in xenophagy. PARKIN deficient 
mice and flies were susceptible to intracellular bacterial 
infections inducing less autophagy, and these indicate that 
PARKIN plays a crucial role in xenophagy (62). Interestingly, 
PARKIN is the best known E3 ubiquitin ligase in mitophagy. 
The PINK-PARKIN pathway is important in the mitophagic 
process (63, 64). PINK1 is a serine/threonine kinase containing 
a mitochondrial targeting sequence in the N-terminus. 
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Normally, PINK1 is imported into the mitochondria and 
anchored at the inner mitochondrial membrane (IMM) and 
then degraded by mitochondrial proteases. However, when 
mitochondria are damaged, PINK1 can’t be imported to IMM, 
but instead accumulates on the outer mitochondria membrane 
(OMM) (65). The accumulated PINK1 recruits a cytosolic E3 
ubiquitin ligase PARKIN and activates PARKIN by phosphory-
lation. Activated PARKIN ubiquitinates certain mitochondrial 
proteins or PARKIN itself. Then, the mitochondrial ubiquitination 
acts as an ‘eat-me’ signal and can be recognized by the 
adaptor p62 through its ubiquitin binding domain. Since p62 
also has an LC3 interacting motif, p62 binds with LC3 on the 
autophagosome and facilitates the degradation of damaged 
mitochondria (44). However, not all mitophagy is processed 
by the PINK-PARKIN pathway. Since mitochondrial proteins 
BCL2/adenovirus E1B 19kDa interacting protein 3 (BNIP3), 
NIP3-like protein X (NIX/BNIP3L) and FUN14 domain containing 
1 (FUNDC1) can directly interact with LC3-II, it is thought that 
other mechanisms exist to enhance mitophagy (66-69). So far 
we have discussed how mitochondria play a crucial role in the 
NLRP3 inflammasome activation, however not many studies 
have been performed concerning the detailed molecular 
mechanisms of mitophagy. Recently, some studies have 
shown how mitophagy is related to the control of NLRP3 
inflammasome activation. Zhong et al. found that the cargo 
receptor p62 is increased by NF-B signaling, and that the 
increased p62 is translocated to damaged mitochondria, which 
are ubiquitinated by Parkin and induce mitophagy (70). 
Consistent with this finding, Kim et al. also observed that p62 
is increased and translocated to damaged mitochondria in 
NLRP3 inflammasome activated cells. Not only p62 but also 
autophagic inducer Sestrin 2 (SESN2) is increased by NO and 
is translocated to damaged mitochondria and protects cells 
from hyperinflammation inducing mitophagy. Additionally, 
SESN2 increases ULK1 stability leading to the initiation of 
autophagy (71). These studies indicate that mitophagy is one 
of the self-limiting systems to protect cells from excessive 
inflammation. 
CONCLUSION
In the past decade, there have been great advances in 
understanding of the NLRP3 inflammasome and autophagy. 
However, knowledge of the link between the NLRP3 in-
flammasome and autophagy, especially mitophagy, is poorly 
understood. Nevertheless we have discussed the role of 
mitophagy as a negative regulator of aberrant NLRP3 in-
flammasome activation, while detailed mechanisms remain 
largely unknown. There are questions that remain to be 
answered. Mitochondrial damage can activate the NLRP3 
inflammasome, but inflammatory cytokines can also trigger 
mitochondrial damage, so it is ambiguous as to which one 
comes first. Since NLRP3 inflammasome activation has a 
beneficial effect so how to regulate activation appropriately it 
should be considered for clinical application. Also, how 
damaged mitochondria serve as ‘eat-me’ signals in the case 
where PINK1 is not mediated should be investigated. Further 
studies are required for a better understanding of the molecular 
mechanisms of mitophagy, but mitochondria remain possible 
therapeutic targets to protect cells from aberrant inflammation. 
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